$0.0130
-0.0007 (-4.92%)
At Close: Jun 03, 2026
Odyssey Group International Completes IND-enabling Studies, Submits Investigator's Brochure for Phase 1 Clinical Trial
09:25am, Wednesday, 04'th Aug 2021
IRVINE, CA, Aug. 04, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTC: ODYY ) (the "Company" or "Odyssey"), a technology and asset acquisition company focused on developing unique, life
Odyssey Group International, Inc. Provides Notice of Annual Meeting of Stockholders
08:32am, Monday, 26'th Jul 2021
IRVINE, CA, July 26, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTCQB: ODYY) ("ODYY" or "the Company"), Odyssey Group International, Inc. (OTCQB:ODYY) (the "Company" or "Odyssey"),
Odyssey Group International Announces Successful Completion of Their Novel Nano-Particle Drug Formulation for Treating Concussion
07:30am, Wednesday, 02'nd Jun 2021
Irvine, CA, June 02, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTCQB: ODYY ) (the "Company" or "Odyssey"), a technology and asset acquisition company focused on developing unique, li
Odyssey Group International Announces Successful Toxicology Studies for its Concussion Drug
07:29am, Wednesday, 26'th May 2021
Enters Agreement with Contract Research Organization for Phase 1 Trial Enters Agreement with Contract Research Organization for Phase 1 Trial
Odyssey Group International, Inc. Schedules Annual Meeting of Stockholders
08:00am, Monday, 24'th May 2021
IRVINE, CA, May 24, 2021 (GLOBE NEWSWIRE) -- – Odyssey Group International, Inc. (OTCQB: ODYY) ("ODYY" or "the Company"), Odyssey Group International, Inc. (OTCQB:ODYY) (the "Company" or "Odyssey"
Odyssey Group International Welcomes Global Operations and Quality Leader Ricky Richardson to Board of Directors
08:05am, Thursday, 13'th May 2021
IRVINE, CA, May 13, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTCQB: ODYY ) (the "Company" or "Odyssey"),a technology and asset acquisition company focused on developing unique, li
Odyssey Group International Announces Formation of Scientific Advisory Board
07:59am, Wednesday, 14'th Apr 2021
Irvine, CA, April 14, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTCQB: ODYY ) (the "Company" or "Odyssey"), a technology and asset acquisition company focused on developing unique, l
IRVINE, CA / ACCESSWIRE / March 10, 2021 / Odyssey Group International, Inc. (OTCQB:ODYY) (the "Company" or "Odyssey"), a technology and asset acquisition company focused on developing unique, life-sa
Odyssey Group International, Inc. Closes Acquisition of Novel Concussion Drug
08:30am, Tuesday, 02'nd Mar 2021
Anticipates initiation of Phase 1 clinical trials of PRV-002 during the Second Quarter of 2021 IRVINE, CA / ACCESSWIRE / March 2, 2021 / Odyssey Group International, Inc. (OTCQB:ODYY) ("Odyssey"), a t
Sign In
Buy ODYY